SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]
SEC Accession No. 0001193125-11-341802
Filing Date
2011-12-15
Accepted
2011-12-15 10:35:37
Documents
1
Filing Date Changed
2011-12-15
Effectiveness Date
2011-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 15-12G d271692d1512g.htm 15-12G 9604
  Complete submission text file 0001193125-11-341802.txt   10620
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 000-27570 | Film No.: 111262589
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1